CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Alho, H.
Right arrow Articles by Krueger, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Alho, H.
Right arrow Articles by Krueger, K. E.

Cell Growth & Differentiation, Vol 5, Issue 9 1005-1014, Copyright © 1994 by American Association of Cancer Research


ARTICLES

Expression of mitochondrial benzodiazepine receptor and its putative endogenous ligand diazepam binding inhibitor in cultured primary astrocytes and C-6 cells: relation to cell growth

H Alho, V Varga and KE Krueger
University of Tampere, Department of Biomedical Science, Finland.

A recognition site for benzodiazepines structurally different from that linked to the gamma-aminobutyric acid receptor subtype A or the "central type" benzodiazepine receptor has been located mainly in the outer membranes of mitochondria and designated mitochondrial benzodiazepine receptor (MBR). A putative endogenous ligand for MBR is the peptide, diazepam binding inhibitor (DBI), which inhibits benzodiazepine ligand binding in mitochondrial membranes. In this study, DBI- and MBR-like immunoreactivities (LI) were examined at the cellular and ultrastructural levels, and their changes during cell growth were followed in rat primary cerebellar astroglial and C-6 cell cultures. During the early stages of the cultures (7-14 days in vitro), MBR and DBI were expressed virtually in all astrocytes and C-6 cells of the cultures. The highest MBR/DBI immunoreactivity was observed in dividing cells. When the astrocytes had formed a confluent layer (21 days in vitro), MBR staining intensity was significantly decreased. Electron microscopic analysis demonstrated an even distribution of DBI-LI throughout the cytoplasm, while MBR-LI was mainly observed in a close association with the outer mitochondrial membranes. However, dividing cells also displayed strong MBR immunoreactivity in endoplasmic reticulum, nuclear membranes, and centrioles. Treatment of the confluent cultures with MBR ligands PK 11195 and Ro 5-4864 at nanomolar concentrations increased the density of MBR-LI and the progesterone content in the medium 2-3-fold over the basal levels. These results demonstrate a close association between DBI and mitochondrial benzodiazepine receptors and lend support to the theory that they have a possible role in the regulation of steroid production. The relation of MBR and DBI expression to cell growth and division suggests a novel role for these elements in the regulation of important intracellular events.


This article has been cited by other articles:


Home page
FASEB J.Home page
C. Rampon, M. Bouzaffour, M. A. Ostuni, P. Dufourcq, C. Girard, J. M. Freyssinet, J.-J. Lacapere, G. Schweizer-Groyer, and S. Vriz
Translocator protein (18 kDa) is involved in primitive erythropoiesis in zebrafish
FASEB J, December 1, 2009; 23(12): 4181 - 4192.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
M. L. James, R. R. Fulton, J. Vercoullie, D. J. Henderson, L. Garreau, S. Chalon, F. Dolle, S. Selleri, D. Guilloteau, and M. Kassiou
DPA-714, a New Translocator Protein-Specific Ligand: Synthesis, Radiofluorination, and Pharmacologic Characterization
J. Nucl. Med., May 1, 2008; 49(5): 814 - 822.
[Abstract] [Full Text] [PDF]


Home page
Biochem. J.Home page
J. S. Hansen, N. J. Faergeman, B. B. Kragelund, and J. Knudsen
Acyl-CoA-binding protein (ACBP) localizes to the endoplasmic reticulum and Golgi in a ligand-dependent manner in mammalian cells
Biochem. J., March 15, 2008; 410(3): 463 - 472.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. A. Ostuni, K. Marazova, G. Peranzi, B. Vidic, V. Papadopoulos, R. Ducroc, and J.- J. Lacapere
Functional characterization and expression of PBR in rat gastric mucosa: stimulation of chloride secretion by PBR ligands
Am J Physiol Gastrointest Liver Physiol, May 7, 2004; 286(6): G1069 - G1080.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
M. Gavish, I. Bachman, R. Shoukrun, Y. Katz, L. Veenman, G. Weisinger, and A. Weizman
Enigma of the Peripheral Benzodiazepine Receptor
Pharmacol. Rev., December 1, 1999; 51(4): 629 - 650.
[Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
A. G. Mensah-Nyagan, J.-L. Do-Rego, D. Beaujean, V. Luu-The, G. Pelletier, and H. Vaudry
Neurosteroids: Expression of Steroidogenic Enzymes and Regulation of Steroid Biosynthesis in the Central Nervous System
Pharmacol. Rev., March 1, 1999; 51(1): 63 - 82.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1994 by the American Association of Cancer Research.